These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Intracellular storage of surfactant and proinflammatory cytokines in co-cultured alveolar epithelium and macrophages in response to increasing CO2 and cyclic cell stretch. Dixon DL; Barr HA; Bersten AD; Doyle IR Exp Lung Res; 2008 Jan; 34(1):37-47. PubMed ID: 18205076 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor production by human sarcoid alveolar macrophages. Bachwich PR; Lynch JP; Larrick J; Spengler M; Kunkel SL Am J Pathol; 1986 Dec; 125(3):421-5. PubMed ID: 3799813 [TBL] [Abstract][Full Text] [Related]
28. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Zelter M; Escudier BJ; Hoeffel JM; Murray JF Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1014-9. PubMed ID: 2327634 [TBL] [Abstract][Full Text] [Related]
29. Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta. Zissel G; Schlaak J; Schlaak M; Müller-Quernheim J Eur Cytokine Netw; 1996; 7(1):59-66. PubMed ID: 8704096 [TBL] [Abstract][Full Text] [Related]
30. STAT1 antisense oligonucleotides attenuate the proinflammatory cytokine release of alveolar macrophages in bleomycin-induced fibrosis. Fan X; Wang Z Cell Mol Immunol; 2005 Jun; 2(3):211-7. PubMed ID: 16212889 [TBL] [Abstract][Full Text] [Related]
31. Modulation of cytokine secretion by garlic oil derivatives is associated with suppressed nitric oxide production in stimulated macrophages. Chang HP; Huang SY; Chen YH J Agric Food Chem; 2005 Apr; 53(7):2530-4. PubMed ID: 15796590 [TBL] [Abstract][Full Text] [Related]
32. Quantitation of the alveolar distribution of surfactant mixtures in normal and injured lungs. Pataki G; Czopf L; Holm BA; Matalon S Am J Respir Cell Mol Biol; 1996 Oct; 15(4):451-9. PubMed ID: 8879178 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic aerosols and airway secretions. Rubin BK J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202 [TBL] [Abstract][Full Text] [Related]
34. Effects of different surfactant preparations on bacterial growth in vitro. Neumeister B; Woerndle S; Bartmann P Biol Neonate; 1996; 70(2):128-34. PubMed ID: 8864432 [TBL] [Abstract][Full Text] [Related]
35. The effect of three surfactant preparations on in vitro lymphocyte functions. Woerndle S; Bartmann P J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541 [TBL] [Abstract][Full Text] [Related]
36. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period. Rauprich P; Möller O; Walter G; Herting E; Robertson B Clin Diagn Lab Immunol; 2000 Sep; 7(5):817-22. PubMed ID: 10973461 [TBL] [Abstract][Full Text] [Related]
37. Susceptibility of exogenous surfactant to phospholipase A2 degradation. Duncan JE; Hatch GM; Belik J Can J Physiol Pharmacol; 1996 Aug; 74(8):957-63. PubMed ID: 8960386 [TBL] [Abstract][Full Text] [Related]